Views & Analysis | Perspectives on pharma industry issues

Digital

pharmaphorum podcast Episode 284, Mati Gill, AION Labs

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

R&D

Auto vacuum sealed vaccines in manufacturing plant

Reliability in life sciences logistics: What good looks like

What constitutes a reliable supply chain is changing rapidly.

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Personal reflections on World ADC, San Diego

At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.

Oncology

ESMO26: Taiho Oncology on improving the lives of patients wi...

Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.

Articles

Will the era of personalised medicine expose a gap in medica...

Ashish Rishi discusses how the era of personalised medicine may expose a gap in medical education and provides his thoughts on how best to overcome this issue. People respond differently to medicines. Fact. Some respond well and their health outcomes are improved. However, some…

Articles

Personalised medicine: prediction is paramount

Alun McCarthy discusses the requirements needed for successful implementation of personalised medicine and how in the future, predictive tests may be key in choosing the best treatments for patients. It may seem self-evident, but it is still worth spelling out: the key to the successful implementation of personalised medicine is the...

Articles

Outsourcing IMP production - a modern twist on a classic tal...

Mike Parry shares his words of wisdom on the hard and soft criteria to consider when choosing a contract manufacturing organisation to deliver a project. Having worked in the pharmaceutical manufacturing sector for many years, I have read a lot of literature about ‘how to choose a...

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

Digital

A sponsored video interview with Axria's Jeff Kaminski

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.